(Q40782194)

23 September 2017

title

N-linked carbohydrates in tyrosinase are required for its recognition by human MHC class II-restricted CD4(+) T cells (English)

1 reference

23 September 2017

Housseau F

1

1 reference

23 September 2017

Moorthy A

2

1 reference

23 September 2017

Langer DA

3

1 reference

23 September 2017

Robbins PF

4

1 reference

23 September 2017

Gonzales MI

5

1 reference

23 September 2017

Topalian SL

6

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

European Journal of Immunology

23 September 2017

published in

1 reference

23 September 2017

volume

31

1 reference

23 September 2017

issue

9

1 reference

23 September 2017

page(s)

2690-2701

1 reference

MHC class II restricted tumor antigens and the role of CD4+ T cells in cancer immunotherapy

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2690%3A%3AAID-IMMU2690%3E3.0.CO%3B2-8

Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2690%3A%3AAID-IMMU2690%3E3.0.CO%3B2-8

Biochemical identification of a mutated human melanoma antigen recognized by CD4(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2690%3A%3AAID-IMMU2690%3E3.0.CO%3B2-8

Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2690%3A%3AAID-IMMU2690%3E3.0.CO%3B2-8

An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2690%3A%3AAID-IMMU2690%3E3.0.CO%3B2-8

Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2690%3A%3AAID-IMMU2690%3E3.0.CO%3B2-8

Mammalian tyrosinase--the critical regulatory control point in melanocyte pigmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2690%3A%3AAID-IMMU2690%3E3.0.CO%3B2-8

An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2690%3A%3AAID-IMMU2690%3E3.0.CO%3B2-8

Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2690%3A%3AAID-IMMU2690%3E3.0.CO%3B2-8

MHC ligands and peptide motifs: first listing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2690%3A%3AAID-IMMU2690%3E3.0.CO%3B2-8

Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2690%3A%3AAID-IMMU2690%3E3.0.CO%3B2-8

Structural requirements of N-glycosylation of proteins. Studies with proline peptides as conformational probes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2690%3A%3AAID-IMMU2690%3E3.0.CO%3B2-8

Glycosylation and the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2690%3A%3AAID-IMMU2690%3E3.0.CO%3B2-8

Get into the groove! Targeting antigens to MHC class II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2690%3A%3AAID-IMMU2690%3E3.0.CO%3B2-8

Introduction of a glycosylation site into a secreted protein provides evidence for an alternative antigen processing pathway: transport of precursors of major histocompatibility complex class I-restricted peptides from the endoplasmic reticulum to t

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2690%3A%3AAID-IMMU2690%3E3.0.CO%3B2-8

Effect of alternative glycosylation on insulin receptor processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2690%3A%3AAID-IMMU2690%3E3.0.CO%3B2-8

Expression and function of a nonglycosylated major histocompatibility class I antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2690%3A%3AAID-IMMU2690%3E3.0.CO%3B2-8

Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2690%3A%3AAID-IMMU2690%3E3.0.CO%3B2-8

Carbohydrate-dependent, HLA class II-restricted, human T cell response to the bee venom allergen phospholipase A2 in allergic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2690%3A%3AAID-IMMU2690%3E3.0.CO%3B2-8

T cell recognition of carbohydrates on type II collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2690%3A%3AAID-IMMU2690%3E3.0.CO%3B2-8

Antigen processing and presentation of a naturally glycosylated protein elicits major histocompatibility complex class II-restricted, carbohydrate-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2690%3A%3AAID-IMMU2690%3E3.0.CO%3B2-8

Epitope glycosylation plays a critical role for T cell recognition of type II collagen in collagen-induced arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2690%3A%3AAID-IMMU2690%3E3.0.CO%3B2-8

Recognition of carbohydrate by major histocompatibility complex class I-restricted, glycopeptide-specific cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2690%3A%3AAID-IMMU2690%3E3.0.CO%3B2-8

Crystal structures of two H-2Db/glycopeptide complexes suggest a molecular basis for CTL cross-reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2690%3A%3AAID-IMMU2690%3E3.0.CO%3B2-8

Presentation of cytosolic glycosylated peptides by human class I major histocompatibility complex molecules in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2690%3A%3AAID-IMMU2690%3E3.0.CO%3B2-8

Phosphorylated peptides are naturally processed and presented by major histocompatibility complex class I molecules in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2690%3A%3AAID-IMMU2690%3E3.0.CO%3B2-8

Melanoma-specific CD4+ T lymphocytes recognize human melanoma antigens processed and presented by Epstein-Barr virus-transformed B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2690%3A%3AAID-IMMU2690%3E3.0.CO%3B2-8

Immunophenotyping of melanomas for tyrosinase: implications for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200109%2931%3A9%3C2690%3A%3AAID-IMMU2690%3E3.0.CO%3B2-8

10.1002/1521-4141(200109)31:9<2690::AID-IMMU2690>3.0.CO;2-8

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference